MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
13.00
+0.36
+2.85%
Opening 10:59 05/07 EDT
OPEN
12.80
PREV CLOSE
12.64
HIGH
13.34
LOW
12.00
VOLUME
14.16K
TURNOVER
--
52 WEEK HIGH
19.93
52 WEEK LOW
7.75
MARKET CAP
99.29M
P/E (TTM)
-1.9429
1D
5D
1M
3M
1Y
5Y
1D
Assembly Biosciences Releases New Preclinical Date For Oral Hepatitis D Virus Entry Inhibitor ABI-6250 And Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 At The EASL Congress 2025 In Amsterdam
Benzinga · 6h ago
Weekly Report: what happened at ASMB last week (0428-0502)?
Weekly Report · 2d ago
Assembly Biosciences Insiders Added US$679.4k Of Stock To Their Holdings
Simply Wall St · 4d ago
Assembly Biosciences Inc <ASMB.OQ> expected to post a loss of $1.60 a share - Earnings Preview
Reuters · 5d ago
Weekly Report: what happened at ASMB last week (0421-0425)?
Weekly Report · 04/28 09:07
Weekly Report: what happened at ASMB last week (0414-0418)?
Weekly Report · 04/21 09:07
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 04/16 12:07
Weekly Report: what happened at ASMB last week (0407-0411)?
Weekly Report · 04/14 09:06
More
About ASMB
More
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small molecule antiviral therapeutics. The Company’s pipeline includes two helicase-primase inhibitors (HPI) targeting recurrent genital herpes, an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, a clinical-stage capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points with the aim of achieving finite treatment and functional cures and research programs focused on the discovery of therapeutics to treat devastating viral diseases, including a non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses and a small molecule interferon-α (IFN-α) receptor (IFNAR) agonist targeting HBV and HDV. HPIs are antiviral agents in development for HSV-1 and HSV-2, with a clinically validated mechanism of action. Its HBV, HSV-1, and HSV-2 programs include ABI-6250, ABI-5366, and ABI-1179.
Recently
Symbol
Price
%Change

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.